ArticleBlood2010

The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody.

Don M Benson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.